
Study shows biomarkers can predict which ER-positive breast cancer patients respond best to first-line therapy
Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to…
Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to…